Novo Nordisk shares rallied on Friday in what’s still been a painful week as the Food and Drug Administration may weigh in on the side of the Danish drugmaker in its dispute over a copycat drug.
Novo Nordisk stock climbs out of hole on FDA chief’s threat to block Hims and Hers pill
Related Posts
Popular News
Latest News
Crypto.com CEO unveils new AI platform that builds intelligent agents for consumers
Kris Marszalek, who built Crypto.com into a global crypto powerhouse, is turning his attention to AI. The entrepreneur said Friday...
Centene 2026 guidance slides: 40% EPS growth target despite revenue headwinds
Centene 2026 guidance slides: 40% EPS growth target despite revenue headwinds
I Tried Malwarebytes’ ChatGPT App, and It’s Actually Good at Detecting Scams
A few months ago, ChatGPT got an app store of its own, which means you can access tools like Photoshop...
Gemini Slashes Staff, Exits Europe Amid Crypto Downturn
Key NotesGemini exits UK, EU and Australia.It also reduces up to 200 employees (~25%).Gemini guided to ~$11,000,000 in pre-tax restructuring...
Welcome to Global Finances Daily, your go-to source for all things finance. Our mission is to provide our readers with valuable information and insights to help them achieve their financial goals and secure their financial future.